Reduced expression and altered subcellular localization of the cyclin- dependent kinase inhibitor p27(Kip1) in human colon cancer

Molecular Carcinogenesis

Volumn 26, Issue 3, 1999, Pages 172-179

  Sgambato, Alessandro ^a   Ratto, Carlo ^a   Faraglia, Beatrice ^a   Merico, Marta ^a   Ardito, Raffaele ^a   Schinzari, Giovanni ^a   Romano, Gianpiero ^a   Cittadini, Achille R M ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Cell cycle; Colon cancer; Cyclin dependent kinase inhibitor; p27(Kip1); Subcellular localization

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P27;

ARTICLE; CELL CYCLE; CELLULAR DISTRIBUTION; COLON CANCER; COLON CARCINOGENESIS; COLON MUCOSA; ENZYME LOCALIZATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

BLOTTING, WESTERN; CARCINOMA; CELL CYCLE PROTEINS; CELL NUCLEUS; COLON; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYTOPLASM; HUMANS; INTESTINAL MUCOSA; MICROTUBULE-ASSOCIATED PROTEINS; SUBCELLULAR FRACTIONS; TUMOR SUPPRESSOR PROTEINS;

EID: 0032704359     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199911)26:3<172::AID-MC6>3.0.CO;2-8     Document Type: Article

References (40)

1. MacLachlan TK, Sang N, Giordano A. Cyclins, cyclin-dependent kinases and Cdk inhibitors: Implications in cell cycle control and cancer. Cnt Rev Eukaryot Gene Expr 1995;5:127-156.
2. Weinstein IB, Zhou P. In: Bertino JR, editor. Encyclopedia of cancer, Vol. 1. New York: Academic Press; 1997; p 256-267.
3. Elledge SJ, Harper JW. Cdk inhibitors: On the threshold of checkpoints and development. Curr Opin Cell Biol 1994;6:847-852.
4. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995;9:1149-1163.
5. INK4/MTS2-related CDK6 inhibitor, correlates with wild-type Rb function. Genes Dev 1994;8:2939-2952.
6. INK4B1. Cancer Res 1996;56:722-727.
7. Serrano M, Lee H-W, Chin L, Cordon-Cardo C, Beach D, DePinto RA. Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996;85:27-37.
8. Kip1, to regions involved in human cancer. Cancer Res 1995;55:1199-1205.
9. Kip1 in primary breast carcinomas. Hum Genet 1996;97:91-94.
10. Kawamata N, Morosetti R, Miller CW, et al. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/ Kip1 in human malignancies. Cancer Res 1995;55: 2266-2269.
11. Kip1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood 1995;86:1924-1930.
12. Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res 1995;55:1206-1210.
13. Kip1: Chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res 1995;55: 1211-1214.
14. Shiohara M, El-Deiry WS, Wada M, et al. Absence of WAF1 mutations in a variety of human malignancies. Blood 1994;84:3781-3784.
15. Spirin KS, Simpson JF, Takeuchi S, Kawamata N, Miller CW, Koeffler HP. p27/Kip1 mutations found in breast cancer. Cancer Res 1996;56:2400-2404.
16. Esposito V, Baldi A, De Luca A, et al. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 1997;57:3381-3385.
17. Loda M, Cukor B, Tam SW, et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 1997;3:231-233.
18. Kip1 protein: Prognostic implications in primary breast cancer. Nat Med 1997;3: 227-230.
19. Porter PL, Malone KE, Heagerty PJ, et al. Expression of cell-cycle regulators p27 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 1997;3:222-225.
20. Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res 1998;58:542-548.
21. Kip1 is associated with advanced stage and invasiveness of gastric carcinomas. Jpn J Cancer Res 1997;88:625-629.
22. Kip1 expression correlates with tumor grade and with reduced disease-free survival in primary superficial bladder cancers. Cancer Res, 1999;59:3245-3250.
23. Kip1. Cancer Res 1996;56:1389-1399.
24. Kip1 in human breast cancers. Clinical Cancer Res 1997;3:1879-1887.
25. Kip1 in multistage colorectal carcinogenesis. Cancer Res 1997;58:114-122.
26. Kip1 and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci USA 1997;94:6380-6385.
27. Kip1 inhibits the growth of both normal and transformed human mammary epithelial cells. Cancer Res 1998;58:3448-3454.
28. Kip1 in anchorage-independent cells. Oncogene 1998;16:2575-2583.
29. Kip1 protein in human prostate cancer correlates with tumor grade. Clinical Cancer Res 1997;3:2269-2274.
30. Singh SP, Lipman J, Goldman H, et al. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinomas. Cancer Res 1998;58:1730-1735.
31. Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and the rectum. Ann Surg 1954;139:846-851.
32. Broders AC. The grading of carcinoma. Minn Med 1925; 8:726-730.
33. Gabriel WB, Dukes C, Bussey HJR. Lymphatic spread in cancer of the colon and the rectum. Br J Surg 1936;23: 395-413.
34. Barboule N, Baldin V, Jozan S, Vidal S, Valette A. Increased level of p21 in human ovarian tumors is associated with increased expression of CDK2, cyclin A and PCNA. Int J Cancer 1998;76:891-896.
35. WAF1/Cip1 in human brain tumors. Oncogene 1995;11: 2021-2028.
36. Kip1 in sarcoma. Proceedings of the American Association for Cancer Research 1999;40:687.
37. Soucek T, Yeung RS, Hengstschlager M. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. Proc Natl Acad Sci USA 1998;95:15653-15658.
38. Kip1 is instigated by Jab1. Nature 1999;398:160-165.
39. Arber N, Hibshoosh H, Moss SF, et al. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 1996;110: 669-674.
40. Cip/Waf1 on growth and differentiation in human colon carcinoma cells. Oncogene 1999;18:103-115.